Delivery Order 75F40118D10020-75F40119F19002
- This is a delivery order contract awarded by the Food and Drug Administration (FDA) to Acumen LLC, doing business as Medric, for the Biologics Effectiveness and Safety (BEST) Initiative. The contract, which is not set aside, has a ceiling value of $22,161,469.00 and a period of performance through September 29, 2025. It is a time and materials contract focused on providing infrastructure and data for surveillance of biologics. Acumen LLC is a for-profit limited liability company that specializes...
- The Food and Drug Administration awarded a $5.45M definitive contract on September 26, 2025, to Acumen LLC (doing business as Medric) for the CBER Biologics Effectiveness and Safety (BEST) Initiative BEST1 Coordinating Center. Under the time-and-materials contract, Medric will provide data analytics, technical assistance, and program coordination services supporting FDA's Center for Biologics Evaluation and Research (CBER) in monitoring the safety and effectiveness of biologic products. The...
- This federal contract was awarded by the Department of Health and Human Services (HHS) Food and Drug Administration (FDA) to Acumen LLC, doing business as Medric, to develop and enhance the FDA's Center for Biologics Evaluation and Research (CBER) capabilities with respect to electronic health data sources, infrastructure, methods, and tools. The purpose is to conduct surveillance and epidemiologic studies to assure the safety and effectiveness of biologic products including vaccines, blood...
- This is a $1,401,628.33 delivery order contract awarded to Acumen LLC, doing business as Medric, by the Centers for Medicare and Medicaid Services (CMS) to provide data support for the Medicare Part D Drug Discount Program. The contract is part of CMS's Small Business Expedited Research and Demonstration (SBRAD) master IDIQ contract vehicle. Medric is a for-profit limited liability company that conducts policy research and data analytics to support federal healthcare programs. This award does...
- This is a $5,017,476.69 Cost Plus Fixed Fee delivery order awarded by the Department of Health and Human Services Centers for Medicare and Medicaid Services (CMS) to Acumen LLC, doing business as Medric. The award falls under the Research, Measurement, Assessment, Design, and Analysis (RMADA) indefinite delivery, indefinite quantity (IDIQ) contract with CMS. Medric provides data analytics, research, technical assistance, and program support services to federal health agencies like CMS, the...
- The Centers for Medicare and Medicaid Services (CMS) awarded a cost-plus-incentive-fee Delivery Order contract valued at $8,492,708.93 to Acumen LLC, doing business as Medric. This contract falls under the Small Business Expedited Research and Demonstration (SBRAD) umbrella contract and covers a variety of data analytics, research, technical assistance, and program support services for CMS, the Food and Drug Administration (FDA), National Institutes of Health (NIH), Health Resources and Services...
- This federal contract award to Acumen LLC, doing business as Medric, is for data modeling and analysis services. The $18,437,998.00 contract was issued as a delivery order under Medric's Multiple Award Schedule (MAS) contract with the U.S. General Services Administration (GSA). The contract has a period of performance through May 15, 2025 and is not set aside for any particular business type. Medric is a for-profit limited liability company that specializes in data analytics, research, and...
- This is a Delivery Order awarded by the National Institute on Aging (NIA), a civilian agency, to Acumen LLC (doing business as Medric), a for-profit limited liability company. The contract is for $49,552.00 and involves Medric executing a Data Use Agreement, providing access to a pilot COVID-19 data tool, facilitating data transfer to the National Institutes of Health (NIH), and assisting NIH grantees with accessing Centers for Medicare & Medicaid Services (CMS) data for COVID-19 research....
- This is a firm fixed-price delivery order contract awarded by the Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Institute on Drug Abuse (NIDA) to Acumen LLC, doing business as Medric, a for-profit limited liability company that provides data analytics, research, and technical assistance to federal agencies. The contract, with a potential value of $1,861,965.63, is for linking Centers for Medicare & Medicaid Services (CMS) data to NIH-supported...
- This is a delivery order contract awarded by the Department of Health and Human Services Centers for Medicare and Medicaid Services (CMS) to Acumen LLC, doing business as Medric, with a potential value of $7,375,912.50. The contract is for policy research and support services, including data analytics, technical assistance, and program support for CMS and other HHS agencies like the Food and Drug Administration (FDA), National Institutes of Health (NIH), and Health Resources and Services...
- 75F40118D10020Indefinite Delivery Contract
- 75F40118D10020-75F40119F19002Delivery Order
This is a delivery order under the BEST Initiative - Data Tools and Infrastructure for Surveillance of Biologics master contract, awarded by the Department of Health and Human Services (HHS) Food and Drug Administration (FDA) to Acumen LLC, doing business as Medric. The contract, which is not set aside, has a potential value of $3,609,297.81 and a completion date of September 15, 2020. Medric is a for-profit limited liability company that conducts policy research and provides data analytics, technical assistance, and program support services to HHS agencies like the Centers for Medicare and Medicaid Services (CMS), National Institutes of Health (NIH), and Health Resources and Services Administration (HRSA). This delivery order is for the BIOLOGICS EFFECTIVENESS AND SAFETY (BEST) INITIATIVE, which aims to develop data, tools, and infrastructure for surveillance of FDA-regulated biologics.
Name | Description | Solicitation Number | FederalAgency | Type | PostedDate |
|---|---|---|---|---|---|
Biologics Effectiveness and Safety (BEST) Initiative: Data, Tools and Infrastructure for Surveillance of Biologics | FDA-18-223-SOL-1196209 | Department of Health and Human Services Food and Drug Administration | Award Notice 1/1 | 5/25/18, 3:46 PM |
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00002 | Close Out | ($46) | 12/29/21 | |
| P00001 | Supplemental Agreement for work within scope | $180.0k | 1/8/20 | |
| Not listed | Not listed | $3.4m | 9/4/19 |